Residency · Washington, DC
Sponsored by George Washington University School of Medicine
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.
JAMA neurology · 2021 · 503 citations · Mitchell Wallin
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
Cell · 2022 · 426 citations · Avindra Nath
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
The Lancet. Neurology · 2023 · 231 citations · Henry Kaminski
Microvascular Injury in the Brains of Patients with Covid-19.
The New England journal of medicine · 2021 · 447 citations · Avindra Nath
Nervous system consequences of COVID-19.
Science (New York, N.Y.) · 2022 · 351 citations · Avindra Nath
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology · 2023 · 218 citations · Henry Kaminski
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations.
The New England journal of medicine · 2023 · 262 citations · Roger Packer
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nature medicine · 2024 · 168 citations · Roger Packer